BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 26300163)

  • 41. QuantiFERON-TB Gold test for screening latent tuberculosis infection in hemodialysis patients.
    Sayarlioğlu H; Gül M; Eren Dağli C; Doğan E; Sahin M; Uçar MA; Köksal N; Sayarlioğlu M; Tahta MK
    Tuberk Toraks; 2011; 59(2):105-10. PubMed ID: 21740383
    [TBL] [Abstract][Full Text] [Related]  

  • 42. QuantiFERON-TB Gold In-Tube test for diagnosis of latent tuberculosis (TB) infection in solid organ transplant candidates: a single-center study in an area endemic for TB.
    Ahmadinejad Z; Azmoudeh Ardalan F; Razzaqi M; Davoudi S; Jafarian A
    Transpl Infect Dis; 2013 Feb; 15(1):90-5. PubMed ID: 23173720
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effects of prophylaxis on QuantiFERON TB-2G responses among children].
    Higuchi K; Okada K; Harada N; Mori T
    Kekkaku; 2008 Sep; 83(9):603-9. PubMed ID: 18979994
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The evaluation of the utility of QuantiFERON TB-Gold In-Tube; QFT-GIT].
    Matsumoto T; Yamazaki T
    Kekkaku; 2014 Sep; 89(9):743-55. PubMed ID: 25730946
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serologic diagnosis of tuberculosis by combining Ig classes against selected mycobacterial targets.
    Baumann R; Kaempfer S; Chegou NN; Oehlmann W; Loxton AG; Kaufmann SH; van Helden PD; Black GF; Singh M; Walzl G
    J Infect; 2014 Dec; 69(6):581-9. PubMed ID: 24968240
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Screening of latent tuberculosis infection in health care workers by QuantiFERON-TB and tuberculin skin test].
    Ciaschetti A; Franchi A; Richeldi L; Rumpianesi F; Meacci M; Valente A; Franco G
    G Ital Med Lav Ergon; 2007; 29(3 Suppl):406-7. PubMed ID: 18409747
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessing the Prevalence of Latent Tuberculosis among Health Care Providers in Zagazig City, Egypt Using Tuberculin Skin Test and QuantiFERON-TB Gold In-Tube Test.
    El-Sokkary RH; Abu-Taleb AM; El-Seifi OS; Zidan HE; Mortada EM; El-Hossary D; Farag SE
    Cent Eur J Public Health; 2015 Dec; 23(4):324-30. PubMed ID: 26841146
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effectiveness of the combination of a whole-blood interferon-gamma assay and the tuberculin skin test in detecting latent tuberculosis infection in rheumatoid arthritis patients receiving adalimumab therapy.
    Chen DY; Shen GH; Hsieh TY; Hsieh CW; Lan JL
    Arthritis Rheum; 2008 Jun; 59(6):800-6. PubMed ID: 18512714
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Negative and positive predictive value of a whole-blood interferon-γ release assay for developing active tuberculosis: an update.
    Diel R; Loddenkemper R; Niemann S; Meywald-Walter K; Nienhaus A
    Am J Respir Crit Care Med; 2011 Jan; 183(1):88-95. PubMed ID: 20802162
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interferon gamma release assays: principles and practice.
    Lalvani A; Pareek M
    Enferm Infecc Microbiol Clin; 2010 Apr; 28(4):245-52. PubMed ID: 19783328
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tuberculosis infection in drug users: interferon-gamma release assay performance.
    Grimes CZ; Hwang LY; Williams ML; Austin CM; Graviss EA
    Int J Tuberc Lung Dis; 2007 Nov; 11(11):1183-9. PubMed ID: 17958979
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Detection of Mycobacterium tuberculosis infection in United States Navy recruits using the tuberculin skin test or whole-blood interferon-gamma release assays.
    Mazurek GH; Zajdowicz MJ; Hankinson AL; Costigan DJ; Toney SR; Rothel JS; Daniels LJ; Pascual FB; Shang N; Keep LW; LoBue PA
    Clin Infect Dis; 2007 Oct; 45(7):826-36. PubMed ID: 17806046
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of tuberculin skin test and Quantiferon immunological assay for latent tuberculosis infection.
    Codecasa LR; Ferrarese M; Penati V; Lacchini C; Cirillo D; Scarparo C; Piccoli P; Piersimoni C; Migliori GB
    Monaldi Arch Chest Dis; 2005 Sep; 63(3):158-62. PubMed ID: 16312206
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of screening procedures for Mycobacterium tuberculosis infection among patients with inflammatory diseases.
    Soborg B; Ruhwald M; Hetland ML; Jacobsen S; Andersen AB; Milman N; Thomsen VO; Jensen DV; Koch A; Wohlfahrt J; Ravn P
    J Rheumatol; 2009 Sep; 36(9):1876-84. PubMed ID: 19648300
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A 100 year update on diagnosis of tuberculosis infection.
    Lalvani A; Pareek M
    Br Med Bull; 2010; 93():69-84. PubMed ID: 19926636
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Latent tuberculosis infection--Revisiting and revising concepts.
    Salgame P; Geadas C; Collins L; Jones-López E; Ellner JJ
    Tuberculosis (Edinb); 2015 Jul; 95(4):373-84. PubMed ID: 26038289
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prospective evaluation of a whole-blood test using Mycobacterium tuberculosis-specific antigens ESAT-6 and CFP-10 for diagnosis of active tuberculosis.
    Ravn P; Munk ME; Andersen AB; Lundgren B; Lundgren JD; Nielsen LN; Kok-Jensen A; Andersen P; Weldingh K
    Clin Diagn Lab Immunol; 2005 Apr; 12(4):491-6. PubMed ID: 15817755
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Profiling the human immune response to Mycobacterium tuberculosis by human cytokine array.
    Chen T; Li Z; Yu L; Li H; Lin J; Guo H; Wang W; Chen L; Zhang X; Wang Y; Chen Y; Liao Q; Tan Y; Shu Y; Huang W; Cai C; Zhou Z; Yu M; Li G; Zhou L; Zhong Q; Bi L; Zhao M; Guo L; Zhou J
    Tuberculosis (Edinb); 2016 Mar; 97():108-17. PubMed ID: 26980502
    [TBL] [Abstract][Full Text] [Related]  

  • 59. QuantiFERON-TB Gold assay for the diagnosis of latent tuberculosis infection.
    Manuel O; Kumar D
    Expert Rev Mol Diagn; 2008 May; 8(3):247-56. PubMed ID: 18598104
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of QuantiFERON(®)-TB Gold In-Tube in tuberculosis contact investigation: experience in a tuberculosis unit.
    Gonzślez-Moreno J; García-Gasalla M; Gállego-Lezaun C; Fernández-Baca V; Mir Viladrich I; Cifuentes-Luna C; Serrano Bujalance A; Salom Vallespir A; Payeras Cifre A
    Infect Dis (Lond); 2015 Apr; 47(4):244-51. PubMed ID: 25692351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.